NCT00614302

Brief Summary

Data collection for better patient characterization in a highly treatment experienced population. Studying the clinical practice for the treatment of HIV multiexperienced patients in the real life. The research will be divided into two phases:

  • The first phase intends to define and understand the clinical practice using a questionnaire about general topics: definitions of multiexperienced patients and VL failure, therapeutic strategies and behaviour in particular cases.
  • The second part of the research will collect the clinical data of double PIs failure patients.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
428

participants targeted

Target at P75+ for all trials

Geographic Reach
1 country

21 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2007

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

January 31, 2008

Completed
13 days until next milestone

First Posted

Study publicly available on registry

February 13, 2008

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2008

Completed
Last Updated

October 2, 2009

Status Verified

October 1, 2009

Enrollment Period

1.3 years

First QC Date

January 31, 2008

Last Update Submit

October 1, 2009

Conditions

Outcome Measures

Primary Outcomes (1)

  • To study in the clinical practice the choice of a specific salvage regimen for multiexperienced patients.

    48 weeks

Secondary Outcomes (1)

  • Reason of each VL failure or switching

    48 weeks

Interventions

TPVDRUG

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

HIV patients

You may qualify if:

  • Patients double PIs failure

You may not qualify if:

  • Not Applicable

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (21)

Boehringer Ingelheim Investigational Site

Ancona, Italy

Location

Boehringer Ingelheim Investigational Site

Bari, Italy

Location

Boehringer Ingelheim Investigational Site

Benevento, Italy

Location

Boehringer Ingelheim Investigational Site

Bisceglie, Italy

Location

Boehringer Ingelheim Investigational Site

Bologna, Italy

Location

Boehringer Ingelheim Investigational Site

Brescia, Italy

Location

Boehringer Ingelheim Investigational Site

Busto, Italy

Location

Boehringer Ingelheim Investigational Site

Caserta, Italy

Location

Boehringer Ingelheim Investigational Site

Catania, Italy

Location

Boehringer Ingelheim Investigational Site

Cremona, Italy

Location

Boehringer Ingelheim Investigational Site

Florence, Italy

Location

Boehringer Ingelheim Investigational Site

Genova, Italy

Location

Boehringer Ingelheim Investigational Site

Legnano, Italy

Location

Boehringer Ingelheim Investigational Site

Milan, Italy

Location

Boehringer Ingelheim Investigational Site

Napoli, Italy

Location

Boehringer Ingelheim Investigational Site

Padua, Italy

Location

Boehringer Ingelheim Investigational Site

Palermo, Italy

Location

Boehringer Ingelheim Investigational Site

Pavia, Italy

Location

Boehringer Ingelheim Investigational Site

Roma, Italy

Location

Boehringer Ingelheim Investigational Site

Sassari, Italy

Location

Boehringer Ingelheim Investigational Site

Torino, Italy

Location

MeSH Terms

Conditions

HIV Infections

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Boehringer Ingelheim

    Boehringer Ingelheim

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

January 31, 2008

First Posted

February 13, 2008

Study Start

June 1, 2007

Primary Completion

October 1, 2008

Last Updated

October 2, 2009

Record last verified: 2009-10

Locations